Last reviewed · How we verify
Doxycyclin
At a glance
| Generic name | Doxycyclin |
|---|---|
| Also known as | Doxyhexal (ATC code J01AA02), COMMON SALT, Doxyclin, Vibramycin, Doxymycin, vibramycin |
| Sponsor | Bulovka Hospital |
| Target | 72 kDa type IV collagenase, Stromelysin-1, Collagenase 3 |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Acne vulgaris
- Actinomycotic infection
- Acute bacterial sinusitis
- Acute gonococcal cervicitis
- Acute gonococcal endometritis
- Acute gonococcal epididymo-orchitis
- Acute gonococcal urethritis
- Anthrax
- Bacterial pneumonia
- Bacterial urinary infection
- Bartonellosis
- Boutonneuse fever
- Brill-Zinsser disease
- Bronchitis
- Brucellosis
- Chancroid
- Chlamydia trachomatis infection of genital structure
- Chlamydial infection
- Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention
- Cholera
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Anorexia
- Maculopapular rashes
- Erythematous rashes
- Photosensitivity
- Glossitis
- Dysphagia
- Skin hyperpigmentation
- Fixed drug eruption
- Tooth discoloration
Serious adverse events
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
- Anaphylaxis
- Intracranial hypertension
- Hemolytic anemia
- Hepatotoxicity
- Esophageal ulcerations
- Thrombocytopenia
- Neutropenia
- Pancreatitis
Key clinical trials
- Doxycycline Use in Post-Operative Seromas (PHASE2)
- A Study of Doxycycline to Treat Chlamydial Infection (PHASE4)
- A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity (PHASE1)
- The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea (NA)
- Doxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF) (NA)
- FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis (PHASE4)
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial (PHASE2)
- Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |